Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

BACKGROUND: According to the 2018 NIA-AA research framework, Alzheimer’s disease (AD) is not defined by the clinical consequences of the disease, but by its underlying pathology, measured by biomarkers. Evidence of both amyloid-β (Aβ) and phosphorylated tau protein (p-tau) deposition—assessed interc...

Descripción completa

Detalles Bibliográficos
Autores principales: Carandini, Tiziana, Arighi, Andrea, Sacchi, Luca, Fumagalli, Giorgio G., Pietroboni, Anna M., Ghezzi, Laura, Colombi, Annalisa, Scarioni, Marta, Fenoglio, Chiara, De Riz, Milena A., Marotta, Giorgio, Scarpini, Elio, Galimberti, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794758/
https://www.ncbi.nlm.nih.gov/pubmed/31615545
http://dx.doi.org/10.1186/s13195-019-0543-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794758/
https://www.ncbi.nlm.nih.gov/pubmed/31615545
http://dx.doi.org/10.1186/s13195-019-0543-7

Ejemplares similares